These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3074028)

  • 1. [The sensitized rate of preformed antibodies in the candidate of renal transplant recipient].
    Nishigaki F; Yoda K; Takahashi T; Takimoto K; Watanabe T; Shimokawa H; Hirano T; Kataoka Y; Yoshiki T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):859-63. PubMed ID: 3074028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell antibodies after planned transfusions.
    van den Berg-Loonen PM; Leunissen KM; Kootstra G; van Hooff JP
    Transplant Proc; 1987 Feb; 19(1 Pt 1):743. PubMed ID: 3274860
    [No Abstract]   [Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization effect.
    Iwaki Y; Terasaki PI
    Clin Transpl; 1986; ():257-65. PubMed ID: 3154413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience of blood transfusion in renal transplantation.
    Frisk B; Berglin E; Blohmé I; Persson H; Sandberg L; Wedel N; Brynger H
    Scand J Urol Nephrol Suppl; 1984; 88():1-69. PubMed ID: 6399773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pre-transplant blood transfusions and haemodialysis on the survival of first kidney grafts from living related donors.
    Solheim BG; Flatmark A; Halvorsen S; Jervell J; Pape J; Thorsby E
    Scand J Urol Nephrol Suppl; 1980; 54():63-6. PubMed ID: 7013047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transfusional anti-HLA hyperimmunization: importance of erythropoietin].
    Mourad G; Chong G; Cristol JP; Lorho R; Ramounau-Pigot A; Seignalet J
    Nephrologie; 1993; 14(2):91-4. PubMed ID: 8327032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
    Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ
    Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-HLA antibodies in nephropathic patients].
    Argiolas M; Piredda GB; Piras P; Corpino AM; Bajorek M; Todde P
    G Ital Nefrol; 2003; 20(4):388-92. PubMed ID: 14523900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic and transplantation biology studies in patients with terminal renal failure].
    Lanzer G
    Wien Med Wochenschr Suppl; 1985; 89():1-48. PubMed ID: 3892933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation by use of splenectomy and transfusions, cadaver haplotype matching, suppressor cell assays, and T-cell monitoring.
    Severyn W; Kyriakides G; Fuller L; Esquenazi V; Flaa C; Olson L; Goldsmith C; Miller J
    Surgery; 1981 Aug; 90(2):364-75. PubMed ID: 6454982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V; Venetz JP; Pantaleo G; Pascual M
    Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living donor transplants.
    Cecka JM
    Clin Transpl; 1995; ():363-77. PubMed ID: 8794280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
    Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
    Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusions as "transplantation pretreatment": incidence of immunization against unfractionated lymphocytes, T- and B-lymphocytes.
    Fehrman I; Opelz G
    Scand J Urol Nephrol Suppl; 1981; 64():93-9. PubMed ID: 6755690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood transfusions given after renal transplantation.
    Scornik JC; Schold JD; Bucci M; Meier-Kriesche HU
    Transplantation; 2009 May; 87(9):1381-6. PubMed ID: 19424040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.